NCT05475886View on ClinicalTrials.gov

6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

April 21, 2024

Study Completion Date

April 21, 2024

Conditions
Adverse Effect
Interventions
DRUG

Hydroxyethyl starch 130/0.4

An initial infusion dose of 500 ml 6% Hydroxyethyl starch (130/0.4) coload simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 100 ml according to the responses of previous patients according to the up-down sequential allocation.

Trial Locations (1)

750004

RECRUITING

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER